Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS sets new tech add-on payment deadline

This article was originally published in The Gray Sheet

Executive Summary

Device makers have until Nov. 20 to submit applications for fiscal year 2011 new technology add-on payments. Under the agency's Inpatient Prospective Payment System, hospitals using a new high-cost medical service or device may receive additional payment, allowing time for claims data to capture the cost of using the new technology within diagnosis related group codes, if the technology is deemed to substantially improve the diagnosis or treatment of Medicare beneficiaries. Last November, six firms applied for the add-on bonus (1"The Gray Sheet" Dec. 1, 2008). However, in the 2010 IPPS rule released July 31, only one device, Spiration's IBV Valve System for post-operative air leaks in the lung, was granted the add-on payment (2"The Gray Sheet" Aug. 10, 2009). Starting Oct. 31, CMS will pay a bonus of up to $3,427.50 for claims involving the device

You may also be interested in...



Lung Valve Device Wins Medicare Inpatient Add-On Payment

The Spiration IBV Valve System is the only product to gain a new technology add-on payment from CMS under the 2010 inpatient prospective payment system rule released July 31

Six Firms Apply For FY 2010 New Technology Add-On Payments

CMS has received four new applications for new technology add-on payments for fiscal 2010, plus two re-applications for devices that were considered last year

Separation Key To Posting Studies Linking Dietary Ingredients To Preventing Or Treating Disease

DSHEA’s Scientific Literature Exemption is attracting attention for offering online studies showing nutrients’ benefits on diseases including COVID-19, though the method isn’t free of risks, suggests CRN executive Megan Olsen.

Topics

UsernamePublicRestriction

Register

LL016481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel